Amgen is moving forward with the launch of Pavblu, its biosimilar to Regeneron’s blockbuster Eylea, following an appeals court decision that ruled against competitor Regeneron …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Kinarus Therapeutics Holding AG / Key word(s): Annual Results 28-Feb-2024 / 07:10 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The
CHICAGO — Daily treatment with a plant-based form of estrogen significantly eased vasomotor symptoms (VMS) in postmenopausal women, the primary efficacy analysis of a phase
An estimated 16% of people worldwide live with a significant disability that impacts their daily life. Of this population, only about 40% engage in aerobic